The results of the RT-qPCR analysis confirmed that the expression of the EIF3B mRNA was elevated in the NAFLD group compared to its expression in the control group, whereas the expression of the RBM15, YTHDC1, and WTAP levels were reduced. The gene discussed is EIF3B; the disease is metabolic dysfunction-associated steatotic liver disease.